Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

Beam Therapeutics rises after the FDA grants orphan drug status to its gene-editing therapy BEAM-101 for sickle cell disease.

Discover the 20 cheapest used 4WD vehicles in Kenya based on Kenya Revenue Authority's new 2025 CRSP schedule that will ...

Discover the 20 cheapest used electric vehicles in Kenya based on Kenya Revenue Authority's new 2025 CRSP schedule that will ...

VTV's blended value approach, attractive dividend yield, and lower volatility make it a strong core holding amid economic ...

CRSP data by YCharts Though it has experienced ... The former received the Regenerative Medicine Advanced Therapy designation from the Food and Drug Administration, a sign that it has shown ...

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling ... the Regenerative Medicine Advanced Therapy designation from the Food and Drug ...

CRISPR Therapeutics AG (NASDAQ:CRSP) has entered a $95 million upfront partnership with China-based Sirius Therapeutics to co-develop an siRNA drug targeting blood clotting disorders. This marks a ...

New Delhi, Observing senior designation couldn't be a monopoly of selected few, the Supreme Court on Tuesday said lawyers practising in subordinate judiciary and other fora must be considered for ...